Pharmacological approach for the reduction of inflammatory and prothrombotic hyperactive state in COVID-19 positive patients by acting on complement cascade

The novel Coronavirus SARS-CoV-2 is the viral pathogen responsible for the ongoing global pandemic, COVID-19 (Coronavirus disease 2019). To date, the data recorded indicate 1.62 Mln deaths and 72.8 Mln people infected (WHO situation report Dec 2020). On December 27, the first anti-COVID-19 vaccinati...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitiello, A., La Porta, R., D'Aiuto, V., Ferrara, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816598/
https://www.ncbi.nlm.nih.gov/pubmed/33632561
http://dx.doi.org/10.1016/j.humimm.2021.01.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816598/
https://www.ncbi.nlm.nih.gov/pubmed/33632561
http://dx.doi.org/10.1016/j.humimm.2021.01.007

Ejemplares similares